ESMO: European Society for Medical Oncology

1. First Global Estimates of Cervical Cancer Attributable to HIV

   Pooled risk of cervical cancer increased in women living with HIV

2. ESMO Immuno-Oncology Virtual Congress 2020

   The ESMO Immuno-Oncology Congress 2020, the European platform dedicated to the development and use of immunotherapies for cancer treatment, will be held as a virtual meeting.

3. FDA Grants Accelerated Approval to Naxitamab for High-Risk Neuroblastoma in Bone or Bone Marrow

   Efficacy was evaluated in Study 201 and Study 12-230

4. EMA Recommends Approval of the Marketing Authorisation for Tagraxofusp

   It is intended for first-line treatment of blastic plasmacytoid dendritic cell neoplasm, a rare and aggressive type of acute myeloid leukaemia

5. EMA Recommends Granting a Marketing Authorisation for a Biosimilar Bevacizumab, Onbevzi

   It received a positive opinion for the treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell carcinoma, epithelial ovarian cancer and carcinoma of the cervix